NASDAQ: SWAVShockwave Medical Inc Stock
$330.54-0.09 (-0.03%)
Updated May 9, 2024
SWAV Price
$330.54
Fair Value Price
-$223.09
Market Cap
$12.41B
52 Week Low
$157.00
52 Week High
$331.58
P/E
74.78x
P/B
16.51x
P/S
15.41x
PEG
5.62x
Dividend Yield
N/A
Revenue
$787.97M
Earnings
$163.50M
Gross Margin
87%
Operating Margin
24.46%
Profit Margin
20.7%
Debt to Equity
1.19
Operating Cash Flow
$198M
Beta
1.29
Next Earnings
May 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A
SWAV Overview
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SWAV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SWAV ($330.54) is overvalued by 248.16% relative to our estimate of its Fair Value price of -$223.09 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SWAV ($330.54) is not significantly undervalued (248.16%) relative to our estimate of its Fair Value price of -$223.09 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SWAV ($330.54) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SWAV due diligence checks available for Premium users.
Be the first to know about important SWAV news, forecast changes, insider trades & much more!
SWAV News
Valuation
SWAV fair value
Fair Value of SWAV stock based on Discounted Cash Flow (DCF)
Price
$330.54
Fair Value
-$223.09
Undervalued by
248.16%
SWAV ($330.54) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SWAV ($330.54) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SWAV ($330.54) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SWAV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
74.78x
Industry
30.45x
Market
29.92x
SWAV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SWAV is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
SWAV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
16.51x
Industry
3.74x
SWAV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SWAV price to earnings growth (PEG)
For valuing profitable companies with growth potential
SWAV is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
SWAV's financial health
Profit margin
Revenue
$218.8M
Net Income
$55.3M
Profit Margin
25.3%
SWAV's Earnings (EBIT) of $192.76M... subscribe to Premium to read more.
Interest Coverage Financials
SWAV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.6B
Liabilities
$892.0M
Debt to equity
1.19
SWAV's short-term assets ($1.28B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SWAV's short-term assets ($1.28B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SWAV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SWAV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$35.8M
Investing
-$84.5M
Financing
$5.0M
SWAV's operating cash flow ($197.93M)... subscribe to Premium to read more.
Debt Coverage Financials
SWAV vs Medical Device Stocks
Shockwave Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.